Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Breast Cancer Radiotherapy Techniques Regarding Secondary Cancer Risk and Normal Tissue Complication Probability - Modelling and Measurements Using a 3D-Printed Phantom.
Vogel M, Gade J, Timm B, Schürmann M, Auerbach H, Nüsken F, Rübe C, Melchior P, Dzierma Y. Vogel M, et al. Among authors: melchior p. Front Oncol. 2022 Jul 27;12:892923. doi: 10.3389/fonc.2022.892923. eCollection 2022. Front Oncol. 2022. PMID: 35965556 Free PMC article.
High-dose treatment for malignant rhabdoid tumor of the kidney: No evidence for improved survival-The Gesellschaft für Pädiatrische Onkologie und Hämatologie (GPOH) experience.
Furtwängler R, Kager L, Melchior P, Rübe C, Ebinger M, Nourkami-Tutdibi N, Niggli F, Warmann S, Hubertus J, Amman G, Leuschner I, Vokuhl C, Graf N, Frühwald MC. Furtwängler R, et al. Among authors: melchior p. Pediatr Blood Cancer. 2018 Jan;65(1). doi: 10.1002/pbc.26746. Epub 2017 Aug 26. Pediatr Blood Cancer. 2018. PMID: 28843054 Clinical Trial.
Randomized phase-III-trial of concurrent chemoradiation for locally advanced head and neck cancer comparing dose reduced radiotherapy with paclitaxel/cisplatin to standard radiotherapy with fluorouracil/cisplatin: The PacCis-trial.
Fietkau R, Hecht M, Hofner B, Lubgan D, Iro H, Gefeller O, Rödel C, Hautmann MG, Kölbl O, Salay A, Rübe C, Melchior P, Breinl P, Krings W, Gripp S, Wollenberg B, Keerl R, Schreck U, Siekmeyer B, Grabenbauer GG, Balermpas P; PacCis-Study Group. Fietkau R, et al. Among authors: melchior p. Radiother Oncol. 2020 Mar;144:209-217. doi: 10.1016/j.radonc.2020.01.016. Epub 2020 Feb 7. Radiother Oncol. 2020. PMID: 32044419 Clinical Trial.
Local Stage Dependent Necessity of Radiation Therapy in Rhabdoid Tumors of the Kidney (RTK).
Melchior P, Dzierma Y, Rübe C, Graf N, Kager L, Dieckmann K, Kroiss S, Hubertus J, Warmann S, Schenk JP, Leuschner I, Nemes K, Meier CM, Vokuhl C, Frühwald M, Furtwängler R. Melchior P, et al. Int J Radiat Oncol Biol Phys. 2020 Nov 1;108(3):667-675. doi: 10.1016/j.ijrobp.2020.04.046. Epub 2020 May 11. Int J Radiat Oncol Biol Phys. 2020. PMID: 32407933
Wilms tumor.
Pater L, Melchior P, Rübe C, Cooper BT, McAleer MF, Kalapurakal JA, Paulino AC. Pater L, et al. Among authors: melchior p. Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28257. doi: 10.1002/pbc.28257. Epub 2020 Sep 7. Pediatr Blood Cancer. 2021. PMID: 32893998 Review.
The SIOP-Renal Tumour Study Group consensus statement on flank target volume delineation for highly conformal radiotherapy.
Janssens GO, Melchior P, Mul J, Saunders D, Bolle S, Cameron AL, Claude L, Gurtner K, van de Ven KP, van Grotel M, Harrabi S, Lassen-Ramshad Y, Lavan N, Magelssen H, Muracciole X, Boterberg T, Mandeville H, Godzinski J, Graf N, van den Heuvel-Eibrink MM, Rübe C. Janssens GO, et al. Among authors: melchior p. Lancet Child Adolesc Health. 2020 Nov;4(11):846-852. doi: 10.1016/S2352-4642(20)30183-8. Lancet Child Adolesc Health. 2020. PMID: 33068550 Review.
57 results